Search & Analyze

IOL Chemicals And Pharmaceuticals Ltd.

HealthcarePharmaceuticals & Drugs

www.iolcp.com BSE: 524164NSE: IOLCP

₹193.65BSE6.58%

16 Sep, 4:01 PM

₹193.65

₹5.68K Cr

33.81

3.05

7.90%

₹198.00

₹173.60

₹219.05

₹67.14

Customise metrics bar

Price Performance

Peer Comparison

Name
SUN PHARMA. SUNPHARMA	1,853.50	36.77	4,44,716.74	0.86	2,901.23	26.53%	15,299.88	10.46%	19.11
DIVI'S LAB. DIVISLAB	9,199.70	83.50	2,44,223.13	0.33	902.00	65.50%	3,080.00	27.80%	21.51
TORRENT PHAR TORNTPHARM	4,823.05	84.11	1,83,453.32	0.79	566.00	3.28%	4,921.00	54.85%	19.27
ZYDUSLIFE ZYDUSLIFE	1,105.00	24.42	1,10,224.17	0.09	990.20	-34.90%	8,017.00	21.96%	21.39
CIPLA LTD. CIPLA	1,359.75	32.59	1,09,848.55	0.96	785.55	-39.18%	7,119.28	2.33%	16.00
LAURUSLABS LAURUSLABS	1,906.00	94.19	1,02,983.51	0.10	362.07	123.94%	2,026.31	29.10%	18.20
DR.REDDY'S DRREDDY	1,145.25	29.67	95,591.76	0.70	435.60	-69.10%	8,099.80	-5.51%	13.75
IOL Chemicals And Pharmaceuticals Ltd. IOLCP	193.65	33.81	5,684.16	0.10	64.40	89.80%	756.26	37.08%	10.65

Quarterly Results

consolidated figures in ₹ Crores · Quarterly

Particulars	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026	Jun 2026
	503.92	502.38	525.75	523.30	527.78	551.69	567.53	580.39	619.45	756.26
Expenses	454.40	451.27	484.18	476.43	465.03	489.55	510.45	523.11	526.98	652.77
	49.52	51.11	41.57	46.87	62.75	62.14	57.08	57.28	92.47	103.49
	9.83%	10.17%	7.91%	8.96%	11.89%	11.26%	10.06%	9.87%	14.93%	13.68%
	7.52	7.38	6.43	4.07	4.53	7.37	6.88	-5.92	1.84	8.18
Interest	3.41	2.15	4.12	4.46	4.03	4.23	3.48	3.63	3.21	3.64
	16.43	16.82	17.94	18.68	18.55	19.77	19.99	20.18	20.29	21.34
	37.20	39.52	25.94	27.80	44.70	45.51	40.49	27.55	70.81	86.69
	25.75%	24.16%	26.18%	26.15%	29.71%	25.44%	25.98%	25.30%	24.93%	25.71%
	27.62	29.97	19.15	20.53	31.42	33.93	29.97	20.58	53.16	64.40
	4.70	5.10	3.26	3.50	1.07	1.16	1.02	0.70	1.81	2.19

Profit & Loss

consolidated figures in ₹ Crores · Annual

Particulars	FY 2021-22 (Mar)	FY 2022-23 (Mar)	FY 2023-24 (Mar)	FY 2024-25 (Mar)	FY 2025-26 (Mar)
No of Months	12.00	12.00	12.00	12.00	12.00
INCOME :
	2,184.02	2,217.11	2,132.79	2,079.21	2,319.06
	2,184.02	2,217.11	2,132.79	2,079.21	2,319.06
EXPENDITURE :
Increase/Decrease in Stock	-52.30	-18.20	-38.25	33.51	-18.53
Raw Material Consumed	1,622.81	1,565.29	1,435.20	1,358.34	1,505.63
Power & Fuel Cost	78.18	131.98	149.05	114.93	154.93
Employee Cost	141.30	168.21	201.02	216.57	248.26
Other Manufacturing Expenses	36.86	43.07	47.67	47.39	58.85
General and Administration Expenses	5.12	6.54	9.01	8.10	6.16
Selling and Distribution Expenses	66.84	61.85	51.25	62.21	54.80
Miscellaneous Expenses	26.92	32.70	47.25	35.86	40.00
	1,925.73	1,991.44	1,902.20	1,876.91	2,050.10
Operating Profit (Excl OI)	258.29	225.67	230.59	202.30	268.96
	32.04	25.61	30.07	22.41	21.38
	290.33	251.28	260.66	224.71	290.34
Interest	8.29	16.47	16.10	14.76	14.55
PBDT	282.04	234.81	244.56	209.95	275.79
	43.26	46.16	62.91	71.99	80.23
Profit Before Taxation & Exceptional Items	238.78	188.65	181.65	137.96	195.56
Exceptional Income / Expenses	-13.93				-11.20
	224.85	188.65	181.65	137.96	184.36
Provision for Tax	57.18	49.51	47.22	36.89	46.72
	167.67	139.14	134.43	101.07	137.64
Extra items				0.00	0.00
Consolidated Net Profit	167.67	139.14	134.43	101.07	137.64
Profit Balance B/F	971.31	1,103.76	1,219.40	1,324.48	1,402.07
Appropriations	1,138.98	1,242.90	1,353.83	1,425.55	1,539.71
Equity Dividend %	40.00%	40.00%	50.00%	40.00%	10.00%
	28.56	23.70	22.90	3.44	4.69
Adjusted EPS	5.71	4.74	4.58	3.44	4.69

Balance Sheet

consolidated figures in ₹ Crores

Particulars	FY 2021-22 (Mar)	FY 2022-23 (Mar)	FY 2023-24 (Mar)	FY 2024-25 (Mar)	FY 2025-26 (Mar)
	58.71	58.71	58.71	58.71	58.71
Total Reserves	1,333.57	1,449.01	1,552.80	1,628.95	1,739.84
Reserve excluding Revaluation Reserve	1,333.57	1,449.01	1,552.80	1,628.95	1,739.84
	1,392.28	1,507.72	1,611.51	1,687.66	1,798.55
Deferred Tax Assets / Liabilities	53.18	56.36	66.14	77.81	84.86
Other Long Term Liabilities	0.43	0.14	0.04		2.40
Long Term Provisions	3.01	1.65	6.71	6.69	10.96
Total Non-Current Liabilities	56.62	58.15	72.89	84.50	98.22
Trade Payables	409.29	314.22	469.18	427.56	482.56
Other Current Liabilities	54.02	54.28	54.67	63.34	69.85
Short Term Borrowings	42.75	79.63	32.76	117.04	132.00
Short Term Provisions	69.23	54.39	40.49	30.64	49.08
Total Current Liabilities	575.29	502.52	597.10	638.58	733.49
Total Liabilities	2,024.19	2,068.39	2,281.50	2,410.74	2,630.26
Gross Block	761.99	995.24	1,235.97	1,544.27	1,632.08
Less: Accumulated Depreciation	201.35	243.43	302.84	373.56	450.51
Net Block	560.64	751.81	933.13	1,170.71	1,181.57
Capital Work in Progress	102.03	81.40	99.83	20.81	93.61
Non Current Investments		17.41	17.41	17.41	17.41
Long Term Investment		17.41	17.41	17.41	17.41
Long Term Loans & Advances	10.77	9.52	23.62	12.15	19.74
Other Non Current Assets	204.87	233.36	49.60	8.53	45.06
Total Non-Current Assets	881.48	1,101.74	1,124.63	1,230.73	1,359.32
Currents Investments	2.37	2.56	2.88	3.30	3.51
Inventories	409.89	325.52	424.84	360.62	371.07
Sundry Debtors	469.80	505.28	471.23	513.69	603.13
Cash and Bank	139.99	21.83	142.89	208.15	198.36
Other Current Assets	30.99	29.86	24.91	26.92	30.10
Short Term Loans and Advances	89.67	81.60	90.12	67.33	64.77
Total Current Assets	1,142.71	966.65	1,156.87	1,180.01	1,270.94
Net Current Assets (Including Current Investments)	567.42	464.13	559.77	541.43	537.45
Total Assets	2,024.19	2,068.39	2,281.50	2,410.74	2,630.26
Contingent Liabilities	0.18	5.35	6.08	5.52	5.66
Total Debt	42.75	79.63	32.76	117.04	132.00
	237.15	256.81	274.49	57.49	61.27
Adjusted Book Value	47.43	51.36	54.90	57.49	61.27

Cash Flow

consolidated figures in ₹ Crores

Particulars	FY 2021-22 (Mar)	FY 2022-23 (Mar)	FY 2023-24 (Mar)	FY 2024-25 (Mar)	FY 2025-26 (Mar)
No of Months	12.00	12.00	12.00	12.00	12.00
	224.85	188.65	181.65	137.96	184.36
Adjustment	33.12	44.41	59.82	79.85	85.04
Changes In working Capital	-102.34	-63.69	90.33	-20.87	-17.22
Cash Flow after changes in Working Capital	155.63	169.37	331.80	196.94	252.18
Cash Flow from Operating Activities	93.05	122.27	289.78	178.62	214.32
Cash Flow from Investing Activities	-120.52	-120.00	-190.98	-154.18	-198.11
Cash Flow from Financing Activitie	-1.64	-4.11	-92.50	46.04	-29.03
Net Cash Inflow / Outflow	-29.11	-1.84	6.30	70.48	-12.82
Opening Cash & Cash Equivalents	32.34	3.23	1.39	7.69	78.17
Closing Cash & Cash Equivalent	3.23	1.39	7.69	78.17	65.35

Ratios

Valuation

33.81

3.05

16.90

2.25

5.73

63.47

Profitability

7.90

10.65

5.46

11.60

5.94

Leverage & Liquidity

0.07

1.73

13.67

Returns

0.10

0.92

Shareholding Pattern

Numbers in percentages

Particulars	Jun '24	Sep '24	Dec '24	Mar '25	Jun '25	Sep '25	Dec '25	Mar '26	Jun '26
	48.19	48.19	52.62	52.62	52.62	52.62	52.62	57.48	62.28
	1.48	1.70	1.56	1.54	2.61	2.29	2.10	1.74	5.30
	50.34	50.11	45.82	45.84	44.77	45.09	45.28	40.78	32.42
	51.81	51.81	47.38	47.38	47.38	47.38	47.38	42.52	37.72
No. of Shareholders	1,28,689	1,25,979	1,26,701	1,30,002	1,25,040	1,36,129	1,33,531	1,31,550	1,19,311

Corporate Actions

Showing: All

Date	Type	Details
2026-08-03	Board Meeting	Quarterly Results
2026-05-20	AGM
2026-05-13	Board Meeting	Audited Results & Quarterly Results

Insider Trading

Date	Person	Category	Transaction Type	Shares	Value (₹)

No insider trading data available.

Sector Overview

HealthcarePharmaceuticals & Drugs

IOL Chemicals And Pharmaceuticals Ltd. operates in the Healthcare sector under the Pharmaceuticals & Drugs industry. This sector is one of the key drivers of the Indian economy and is closely tracked by the relevant Nifty sectoral index.

Company Profile

Corporate information and contact details

Key Management

9 members across the board and senior leadership

Rajender Mohan Malla

Chairman

₹4.50 L

Mar '26

Vikas Gupta

Joint Managing Director

₹3.49 Cr

Mar '26

Varinder Gupta

Managing Director

₹11.41 Cr

Mar '26

Abhiraj Gupta

Whole Time Director

₹1.66 Cr

Mar '26

Kushal Kumar Rana

Whole Time Director - Works

₹1.96 Cr

Mar '26

Harpal Singh

Non Executive Independent Director

₹8.50 L

Mar '26

Rajni Jha

Non Executive Independent Director

₹6.50 L

Mar '26

Sharad Tyagi

Non Executive Independent Director

₹11.50 L

Mar '26

Abhay Raj Singh

Senior Vice President & Company Secretary, Compliance Officer

—

IOLCP Latest News

News

1 of 1 article

EQUITY20 May 2026 · 14:36

IOL Chem & Pharma reports Profit after tax of Rs 531.80 Mln, in the March 2026 quarter

IOLCP

₹193.65

+6.58%